As of Nov 27
| +1.24 / +0.94%|
The 30 analysts offering 12-month price forecasts for Bayer have a median target of 149.30, with a high estimate of 169.89 and a low estimate of 123.84. The median estimate represents a +11.80% increase from the last price of 133.54.
The current consensus among 31 polled investment analysts is to Buy stock in Bayer. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.